NPI registry status
Active
2026 NPPES data Pediatric Hematology & Oncology Physician NPI 1487689295 M.D.
Verify on CMS → James Taylor, M.D.
Pediatric Hematology & Oncology Physician in Washington, District of Columbia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 2,574 in Pediatric Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
454
Medicare Part D claims · 29 beneficiaries · Pediatric Hematology & Oncology Physician avg: 92
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$23.48
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
James Taylor, M.D. filed 454 Medicare Part D claims in 2023 as a Pediatric Hematology & Oncology Physician in Washington, District of Columbia, prescribing 83% generic.
- 454
- Part D claims, 2023
- 83%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
James Taylor, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
454 Top 38% higher than 62% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
James Taylor, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about James Taylor, M.D.?
Quality data not reportedPrimary specialty
Pediatric Hematology & Oncology Physician
Medicare Part D claims
454 393% vs specialty avg
Specialty distribution in District of Columbia
How Pediatric Hematology & Oncology Physician compares to other specialties among District of Columbia providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
James Taylor, M.D. appears in the CMS NPPES registry as a Pediatric Hematology & Oncology Physician provider holding M.D. credentials at 2041 GEORGIA AVE NW STE B&C, Washington, DC, 20060, with a listed phone of (202) 865-3118. NPI 1487689295 was issued on 07/11/2006.
Medicare Part D records for calendar year 2023 show 454 prescription claims written by this provider, covering 29 Medicare beneficiaries and totaling roughly $534K in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 40.5%.
Pediatric Hematology & Oncology Physician is a narrow specialty nationwide, with 2,574 enrolled providers across 52 states and an average of 92 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487689295 |
|---|---|
| Specialty | Pediatric Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/11/2006 |
Hospital and facility affiliations
Facilities where James Taylor, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Howard University
Washington, DC
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for James Taylor, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$23
Largest payer
PFIZER INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
James Taylor, M.D. - brand share 17.0%
Pediatric Hematology & Oncology Physician average
17% brand-name claims vs 83% generic, on 454 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
454
Total Claims
$534K
Total Drug Cost
29
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 488
- Total Day Supply
- 10,915
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $495K
- Generic Drug Cost
- $39K
- Opioid Claims
- 184 (40.5% rate)
Patient Demographics
- Average Patient Age
- 46.2 years
- Avg HCC Risk Score
- 4.98
- Gender Split
- 48% female / 52% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What James Taylor, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Oxycodone Hcl
Oxycodone Hcl
47 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
40 claims
- Adakveo
Adakveo
34 claims
- Morphine Sulfate Er
Morphine Sulfate Er
31 claims
- Hydroxyurea
Hydroxyurea
30 claims
- Ibuprofen
Ibuprofen
30 claims
- Hydromorphone Hcl
Hydromorphone Hcl
27 claims
- Methadone Hcl
Methadone Hcl
24 claims
| Drug | Claims |
|---|---|
| Oxycodone Hcl | 47 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 40 |
| Adakveo Crizanlizumab-Tmca | 34 |
| Morphine Sulfate Er Morphine Sulfate | 31 |
| Hydroxyurea | 30 |
| Ibuprofen | 30 |
| Hydromorphone Hcl | 27 |
| Methadone Hcl | 24 |
| Zolpidem Tartrate | 21 |
| Oxycontin Oxycodone Hcl | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Pediatric Hematology & Oncology Physician in DC →
All providers in District of Columbia →
Compare specialties →
Pediatric Hematology & Oncology Physician Overview
How James Taylor, M.D. fits within the Pediatric Hematology & Oncology Physician landscape nationally.
2,574
Pediatric Hematology & Oncology Physician Providers in US
52
States with Pediatric Hematology & Oncology Physician
92
Avg Claims per Provider
James Taylor, M.D.'s 454 claims are above the specialty average of 92.
Nearby Pediatric Hematology & Oncology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as Taylor.
Dr. Allistair Abraham
M.D.
Washington, DC
Amal Abu-Ghosh
Washington, DC
Dr. Barry Anderson
MD, PHD
Washington, DC
Dr. Anne Angiolillo
MD
Washington, DC
Dr. Catherine Bollard
MD
Washington, DC
Compare Pediatric Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the District of Columbia medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pediatric Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore District of Columbia
Frequently Asked Questions
What is James Taylor, M.D.'s specialty? ▼
James Taylor, M.D. specializes in Pediatric Hematology & Oncology Physician and practices in Washington, District of Columbia. Credentials: M.D..
How much does James Taylor, M.D. prescribe under Medicare Part D? ▼
In 2023, James Taylor, M.D. wrote 454 Medicare Part D claims totaling $534K in drug costs for 29 beneficiaries.
Where is James Taylor, M.D. located? ▼
James Taylor, M.D. is located at 2041 GEORGIA AVE NW STE B&C, Washington, DC, 20060. Phone: (202) 865-3118.
What is James Taylor, M.D.'s NPI number? ▼
James Taylor, M.D.'s National Provider Identifier (NPI) is 1487689295, issued on 07/11/2006.
Does James Taylor, M.D. prescribe more brand-name or generic drugs? ▼
James Taylor, M.D.'s prescribing is 17% brand-name and 83% generic drugs by claim count, with $495K in brand drug costs.
Does James Taylor, M.D. prescribe opioids? ▼
Yes, James Taylor, M.D. had 184 opioid claims in 2023 with an opioid prescribing rate of 40.5%.
How many Pediatric Hematology & Oncology Physician providers are there in the US? ▼
There are 2,574 Pediatric Hematology & Oncology Physician providers across 52 states in the US. The average Pediatric Hematology & Oncology Physician provider writes 92 Medicare Part D claims per year.
What drugs does James Taylor, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, James Taylor, M.D.'s most frequently prescribed drugs include Oxycodone Hcl, Oxycodone-Acetaminophen, Adakveo. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does James Taylor, M.D. accept Medicare? ▼
James Taylor, M.D. appears in CMS Medicare data with 454 Part D claims and 29 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify James Taylor, M.D.'s credentials? ▼
James Taylor, M.D.'s NPI is 1487689295 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.